Supplemental Material - Regulatory Experience Assessing the Carcinogenic Potential of a Monoclonal Antibody Inhibiting PCSK9, Bococizumab, Including a 2-Year Carcinogenicity Study in Rats
收藏数据链接：
官方服务：
资源简介：
Supplemental Material for Regulatory Experience Assessing the Carcinogenic Potential of a Monoclonal Antibody Inhibiting PCSK9, Bococizumab, Including a 2-Year Carcinogenicity Study in Rats by Bernard S. Buetow, Gregg D Cappon, Laura M. Aschenbrenner, Lawrence Updyke, Vince R. Torti, Mark Evans6\, Shana R. Dalton, Steven Bailey, and Christopher J Bowman in International Journal of Toxicology
提供机构：
SAGE Journals创建时间：
2022-06-10
